374 related articles for article (PubMed ID: 22480333)
1. Piceatannol suppresses breast cancer cell invasion through the inhibition of MMP-9: involvement of PI3K/AKT and NF-κB pathways.
Ko HS; Lee HJ; Kim SH; Lee EO
J Agric Food Chem; 2012 Apr; 60(16):4083-9. PubMed ID: 22480333
[TBL] [Abstract][Full Text] [Related]
2. Curcumol Suppresses Breast Cancer Cell Metastasis by Inhibiting MMP-9 Via JNK1/2 and Akt-Dependent NF-κB Signaling Pathways.
Ning L; Ma H; Jiang Z; Chen L; Li L; Chen Q; Qi H
Integr Cancer Ther; 2016 Jun; 15(2):216-25. PubMed ID: 27125675
[TBL] [Abstract][Full Text] [Related]
3. Tianeptine sodium salt suppresses TNF-α-induced expression of matrix metalloproteinase-9 in human carcinoma cells via suppression of the PI3K/Akt-mediated NF-κB pathway.
Jayasooriya RG; Dilshara MG; Choi YH; Moon SK; Kim WJ; Kim GY
Environ Toxicol Pharmacol; 2014 Sep; 38(2):502-9. PubMed ID: 25168152
[TBL] [Abstract][Full Text] [Related]
4. Aromatic-turmerone attenuates invasion and expression of MMP-9 and COX-2 through inhibition of NF-κB activation in TPA-induced breast cancer cells.
Park SY; Kim YH; Kim Y; Lee SJ
J Cell Biochem; 2012 Dec; 113(12):3653-62. PubMed ID: 22740037
[TBL] [Abstract][Full Text] [Related]
5. Camptothecin suppresses expression of matrix metalloproteinase-9 and vascular endothelial growth factor in DU145 cells through PI3K/Akt-mediated inhibition of NF-κB activity and Nrf2-dependent induction of HO-1 expression.
Jayasooriya RG; Park SR; Choi YH; Hyun JW; Chang WY; Kim GY
Environ Toxicol Pharmacol; 2015 May; 39(3):1189-98. PubMed ID: 25941985
[TBL] [Abstract][Full Text] [Related]
6. Induction of heme oxygenase-1 and inhibition of TPA-induced matrix metalloproteinase-9 expression by andrographolide in MCF-7 human breast cancer cells.
Chao CY; Lii CK; Hsu YT; Lu CY; Liu KL; Li CC; Chen HW
Carcinogenesis; 2013 Aug; 34(8):1843-51. PubMed ID: 23615401
[TBL] [Abstract][Full Text] [Related]
7. Suppression of phorbol-12-myristate-13-acetate-induced tumor cell invasion by bergamottin via the inhibition of protein kinase Cdelta/p38 mitogen-activated protein kinase and JNK/nuclear factor-kappaB-dependent matrix metalloproteinase-9 expression.
Hwang YP; Yun HJ; Choi JH; Kang KW; Jeong HG
Mol Nutr Food Res; 2010 Jul; 54(7):977-90. PubMed ID: 19943262
[TBL] [Abstract][Full Text] [Related]
8. Suppression of MMP-9 and FAK expression by pomolic acid via blocking of NF-κB/ERK/mTOR signaling pathways in growth factor-stimulated human breast cancer cells.
Park JH; Cho YY; Yoon SW; Park B
Int J Oncol; 2016 Sep; 49(3):1230-40. PubMed ID: 27573547
[TBL] [Abstract][Full Text] [Related]
9. Metastatic function of BMP-2 in gastric cancer cells: the role of PI3K/AKT, MAPK, the NF-κB pathway, and MMP-9 expression.
Kang MH; Oh SC; Lee HJ; Kang HN; Kim JL; Kim JS; Yoo YA
Exp Cell Res; 2011 Jul; 317(12):1746-62. PubMed ID: 21570392
[TBL] [Abstract][Full Text] [Related]
10. Frondoside A has an anti-invasive effect by inhibiting TPA-induced MMP-9 activation via NF-κB and AP-1 signaling in human breast cancer cells.
Park SY; Kim YH; Kim Y; Lee SJ
Int J Oncol; 2012 Sep; 41(3):933-40. PubMed ID: 22710811
[TBL] [Abstract][Full Text] [Related]
11. Kalopanaxsaponin A inhibits PMA-induced invasion by reducing matrix metalloproteinase-9 via PI3K/Akt- and PKCdelta-mediated signaling in MCF-7 human breast cancer cells.
Park SK; Hwang YS; Park KK; Park HJ; Seo JY; Chung WY
Carcinogenesis; 2009 Jul; 30(7):1225-33. PubMed ID: 19420016
[TBL] [Abstract][Full Text] [Related]
12. Lunasin suppresses the migration and invasion of breast cancer cells by inhibiting matrix metalloproteinase-2/-9 via the FAK/Akt/ERK and NF-κB signaling pathways.
Jiang Q; Pan Y; Cheng Y; Li H; Liu D; Li H
Oncol Rep; 2016 Jul; 36(1):253-62. PubMed ID: 27175819
[TBL] [Abstract][Full Text] [Related]
13. Ang II-AT1R increases cell migration through PI3K/AKT and NF-κB pathways in breast cancer.
Zhao Y; Wang H; Li X; Cao M; Lu H; Meng Q; Pang H; Li H; Nadolny C; Dong X; Cai L
J Cell Physiol; 2014 Nov; 229(11):1855-62. PubMed ID: 24692224
[TBL] [Abstract][Full Text] [Related]
14. 18β-Glycyrrhetinic acid suppresses TNF-α induced matrix metalloproteinase-9 and vascular endothelial growth factor by suppressing the Akt-dependent NF-κB pathway.
Jayasooriya RG; Dilshara MG; Park SR; Choi YH; Hyun JW; Chang WY; Kim GY
Toxicol In Vitro; 2014 Aug; 28(5):751-8. PubMed ID: 24613819
[TBL] [Abstract][Full Text] [Related]
15. Surfactin suppresses TPA-induced breast cancer cell invasion through the inhibition of MMP-9 expression.
Park SY; Kim JH; Lee YJ; Lee SJ; Kim Y
Int J Oncol; 2013 Jan; 42(1):287-96. PubMed ID: 23151889
[TBL] [Abstract][Full Text] [Related]
16. Selective inhibition of MMP-9 gene expression by mangiferin in PMA-stimulated human astroglioma cells: involvement of PI3K/Akt and MAPK signaling pathways.
Jung JS; Jung K; Kim DH; Kim HS
Pharmacol Res; 2012 Jul; 66(1):95-103. PubMed ID: 22465218
[TBL] [Abstract][Full Text] [Related]
17. Praeruptorin-B Inhibits 12-O-Tetradecanoylphorbol-13-Acetate-Induced Cell Invasion by Targeting AKT/NF-κB via Matrix Metalloproteinase-2/-9 Expression in Human Cervical Cancer Cells.
Hung CY; Lee CH; Chiou HL; Lin CL; Chen PN; Lin MT; Hsieh YH; Chou MC
Cell Physiol Biochem; 2019; 52(6):1255-1266. PubMed ID: 31026389
[TBL] [Abstract][Full Text] [Related]
18. Hepatocyte growth factor (HGF) upregulates heparanase expression via the PI3K/Akt/NF-κB signaling pathway for gastric cancer metastasis.
Hao NB; Tang B; Wang GZ; Xie R; Hu CJ; Wang SM; Wu YY; Liu E; Xie X; Yang SM
Cancer Lett; 2015 May; 361(1):57-66. PubMed ID: 25727320
[TBL] [Abstract][Full Text] [Related]
19. Metastatic potential in MDA-MB-231 human breast cancer cells is inhibited by proton beam irradiation via the Akt/nuclear factor-κB signaling pathway.
Lee KS; Lee DH; Chun SY; Nam KS
Mol Med Rep; 2014 Aug; 10(2):1007-12. PubMed ID: 24859472
[TBL] [Abstract][Full Text] [Related]
20. Quercetin inhibits migration and invasion of SAS human oral cancer cells through inhibition of NF-κB and matrix metalloproteinase-2/-9 signaling pathways.
Lai WW; Hsu SC; Chueh FS; Chen YY; Yang JS; Lin JP; Lien JC; Tsai CH; Chung JG
Anticancer Res; 2013 May; 33(5):1941-50. PubMed ID: 23645742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]